Bellevue Healthcare Trust update with Doceo

Bellevue Healthcare Trust PLC
13 February 2024
 

 

 

Bellevue Healthcare Trust (BBH) has launched new video content with Doceo.

 

Bellevue Healthcare Trust intends to invest in a concentrated portfolio of listed or quoted equities in the global healthcare industry. The investable universe for the fund is the global healthcare industry including companies within industries such as pharmaceuticals, biotechnology, medical devices and equipment, healthcare insurers and facility operators, information technology (where the product or service supports, supplies or services the delivery of healthcare), drug retail, consumer healthcare and distribution.

 

Brett Darke, co-manager of the Bellevue Healthcare Trust, explains why the team believe that now is a compelling time to be seeking opportunities in the mid cap healthcare space. Darke observes that, although valuations have fallen to new lows, the market expectations for portfolio company revenues remain unchanged. While interest rates do play a meaningful role in performance, Darke points to history to explain that it is possible to invest in mid cap healthcare growth stocks in a tightening rate environment.

 

 


 

 

For the update from BBH, visit: https://doceo.tv/funds/bb-healthcare/

For further information on Doceo please visit www.doceo.tv or contact the team on info@doceo.tv

 

 

 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings